SCHEMBL21428975

SCHEMBL21428975

C=CC/C=C(/N=C)c1ccc(F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 1/20 0.35
▸ CES1 P23141 1/20 0.35
▸ MAOA P21397 2/20 0.35
▸ MAOB P27338 2/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ PTPN1 P18031 1/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ LMNA P02545 1/20 0.34
▸ PTBP1 P26599 1/20 0.34
▸ CA1 P00915 2/20 0.33
▸ CA2 P00918 2/20 0.33
▸ GAA P10253 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29337015 0.69 SMN1; SMN2 (0.36) CES2CES1MAOAMAOBNPC1
SCHEMBL19495183 0.69 GAA (0.40) MAOAMAOBRAB9ASMN1; SMN2LMNA
SCHEMBL19073928 0.67 HPGD (0.36) NPC1RAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL17868843 0.65 MAOA (0.52) CES2CES1MAOAMAOBNPC1
SCHEMBL28911310 0.65 DRD4 (0.37) CES2CES1MAOAMAOBNPC1
SCHEMBL28911309 0.65 DRD4 (0.37) CES2CES1MAOAMAOBNPC1
SCHEMBL8553233 0.64 CES2 (0.42) CES2CES1MAOAMAOBNPC1
SCHEMBL28398411 0.64 SMN1; SMN2 (0.49) NPC1RAB9ASMN1; SMN2LMNAPTBP1
SCHEMBL31051245 0.64 CES2 (0.34) CES2CES1MAOAMAOBNPC1
SCHEMBL8519584 0.64 NPC1 (0.55) CES2CES1NPC1RAB9APTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019185631-A1 4—(1H— IMIDAZOL— 5— YL) -1H-PYRROLO [2, 3-B] PYRIDINES FOR USE IN THE TREATMENT OF LEUKAEMIAS, LYMPHOMAS AND SOLID TUMORS MASARYKOVA UNIVERZITA (CZ) 2019-10-03 — — WO disclosed
Send feedback